Amicus Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Conference

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on December 1, 2020, at 2:15 p.m. E.T. Interested parties can listen to the event through a live audio webcast available on the company’s corporate website. Amicus is dedicated to developing innovative treatments for rare metabolic diseases, reflecting its commitment to patient care and a robust pipeline of novel therapies. For more details, visit their website.

News Market Reaction – FOLD

+1.87%

+1.87% Session move

In the trading session that priced this news, FOLD gained 1.87%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CRANBURY, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the Evercore ISI 3^rd Annual HealthCONx Conference being held virtually on Tuesday, December 1, 2020 at 2:15 p.m. E.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Director, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

What is the date and time of the Amicus Therapeutics fireside chat?

The Amicus Therapeutics fireside chat is scheduled for December 1, 2020, at 2:15 p.m. E.T.

Where can I access the live audio webcast of the Amicus Therapeutics presentation?

The live audio webcast can be accessed via the investors section of the Amicus Therapeutics corporate website.

What is the stock symbol for Amicus Therapeutics?

The stock symbol for Amicus Therapeutics is FOLD.

What does Amicus Therapeutics focus on developing?

Amicus Therapeutics focuses on discovering and developing innovative medicines for rare metabolic diseases.

Who can I contact for investor relations at Amicus Therapeutics?

For investor relations, you can contact Andrew Faughnan at Amicus Therapeutics.